Document Detail

microRNAs in mantle cell lymphoma.
MedLine Citation:
PMID:  23339447     Owner:  NLM     Status:  Publisher    
Abstract Mantle cell lymphoma (MCL) is rare and aggressive subtype of non-Hodgkin lymphoma. New treatment modalities, including intensive induction regimens with immunochemotherapy and autologous stem cell transplantation, have improved survival, however, many patients still relapse, and there is a need for novel therapeutic strategies. Recent progress has been made in the understanding of the role of microRNAs (miRNAs) in MCL. Comparisons of tumor samples from MCL patients to their normal counterparts (naïve B-cells) have identified differentially expressed miRNAs with roles in cellular growth and survival pathways, as demonstrated in various biological model systems. In addition, MCL clinico-pathological and prognostic subtypes can be identified by using individual miRNAs or miRNA classifiers. miRNA based therapies have now shown efficacy in animal models, and many efforts are currently being done to further develop these drugs for use in patients. Thus, there is hope that specific targeting of pathogenic miRNAs may be used in MCL cases when conventional therapies fail. Here, we review the current knowledge about the role of miRNAs in MCL, and highlight the perspectives for clinical use.
Simon Husby; Christian Geisler; Kirsten Grønbæk
Related Documents :
24569377 - Central memory cd8+ t lymphocytes mediate lung allograft acceptance.
23521677 - Oleocanthal inhibits proliferation and mip-1α expression in human multiple myeloma cells.
24038087 - Cd4+ t cell expression of myd88 is essential for normal resolution of chlamydia muridar...
24853377 - Labelling and tracking of human mesenchymal stromal cells in preclinical studies and la...
11793857 - Expression of hhr21sp gene by peripheral blood and hematopoietic cells of normal subjec...
86527 - Cell-mediated reactivity to antigens shared by moloney-virus-induced lymphomas (lstra) ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-23
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  -     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells.
Next Document:  Role of serum high mobility group box 1 in hematological malignancies complicated with systemic infl...